Johnson & Johnson vaccine pause lifted after fortnight

Monday, April 26th, 2021 00:00 |
Johnson & Johnson
Johnson & Johnson.
Johnson & Johnson

Kenya has approved China's Sinopharm vaccine as the country intensifies the fight against COVID-19 targeting high-risk groups, an official confirmed to Xinhua Thursday.

Willis Akhwale, head of COVID-19 Vaccine Taskforce in Ministry of Health, said that Pharmacy and Poisons Board, Kenya's medical regulatory body, has approved Sinopharm, which has been granted emergency use by the World Health Organization to boost ongoing inoculation against the virus. 

"Kenya has approved Sinopharm. We have confidence in its efficacy since it has been certified by WHO," said Akhwale, adding that the east African nation had given a nod to China-made vaccine alongside three others as it targets to immunize 10 percent of the adult population by year's end.

 As of Wednesday, Kenya had recorded 224,400 confirmed cases, with 2.8 percent of adults fully vaccinated.

More on World